Pharmabiz29m
Bayer announces positive results of pivotal phase III QUANTI studies of gadoquatrane, an investigational GBCA for use in magnetic resonance imaging
Bayer announces positive results of pivotal phase III QUANTI studies of gadoquatrane, an investigational GBCA for use in magnetic resonance imaging: Berlin Monday, January 13, 202 ...
Pharmabiz2h
ASPA to host 6th edition of Traceability and Authentication Forum 2025 on March 17 & 18 at New Delhi
ASPA to host 6th edition of Traceability and Authentication Forum 2025 on March 17 & 18 at New Delhi: Our Bureau, Bengaluru Monday, January 13, 2025, 09:00 Hrs [IST] The Authentic ...
Pharmabiz1h
New European Union rules for health technology assessments become effective
New European Union rules for health technology assessments become effective: Amsterdam, The Netherlands Monday, January 13, 2025, 10:00 Hrs [IST] EMA is ready to support the imple ...
Pharmabiz3h
Molbio Diagnostics redefines molecular diagnostics with Truenat
Molbio Diagnostics redefines molecular diagnostics with Truenat: Monday, January 13, 2025, 08:00 Hrs [IST] In a world marked by significant healthcare disparities and the rising b ...
Pharmabiz3h
KPRDO asks FDA to take action against Swiggy & PharmEasy for drug delivery in 10 minutes
KPRDO asks FDA to take action against Swiggy & PharmEasy for drug delivery in 10 minutes: Nandita Vijayasimha, Bengaluru ...
Pharmabiz3h
Allowing separate timelines for large units and MSMES may create two categories of manufacturing facilities: Experts
Gireesh Babu, New Delhi Monday, January 13, 2025, 08:00 Hrs [IST] ...
Pharmabiz3h
MP DCA forms team of regulatory officers to assist pharma units in upgrading plants as per revised Schedule M
Peethaambaran Kunnathoor, Chennai Monday, January 13, 2025, 08:00 Hrs [IST] ...
Pharmabiz3h
Panel asks govt to provide duty concessions, reduced GST rates for growth of medical devices manufacturing
Panel asks govt to provide duty concessions, reduced GST rates for growth of medical devices manufacturing: Gireesh Babu, New Delhi Monday, January 13, 2025, 08:00 Hrs [IST] A Par ...
Pharmabiz3h
Exporters concerned over delay in getting relief under Section 43B(h) of IT Act
Exporters concerned over delay in getting relief under Section 43B(h) of IT Act: Shardul Nautiyal, Mumbai Monday, January 13, 2025, 08:00 Hrs [IST] India’s pharmaceutical export ...
Pharmabiz1d
Boehringer Ingelheim broadens oncology portfolio with license for Synaffix’s ADC technology
Boehringer Ingelheim and Synaffix B.V. (Synaffix), a Lonza company focused on commercializing its clinical-stage platform technology for the development of best-in-class antibody-drug conjugates (ADCs ...
Pharmabiz1d
Astellas Pharma announces US FDA confirms Class 1 resubmission of the sNDA for Izervay for geographic atrophy
Astellas Pharma Inc. announced the US Food and Drug Administration (FDA) accepted the revised supplemental New Drug Application (sNDA) for Izervay (avacincaptad pegol intravitreal solution) for the ...
Pharmabiz1d
Gaelic Labs establishes subsidiary in UAE, enabling access to growing Middle East pharma market
Gaelic Laboratories, a European CMO based in Ireland, has established a subsidiary in the UAE, enabling access to the Middle East market – both for Gaelic Laboratories and its marketing partners ...